Herlev Hospital is a hospital in Herlev, Denmark, close to Copenhagen. The building is 120 metres tall and has 25 floors. It is famous for being Denmark's tallest building. Its modern, functional architecture in bright concrete, glass and bronze-colored aluminum gives a unique impression.

During the past decade, Herlev Gentofte Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herlev Gentofte Hospital" #1 sponsor was "Herlev Hospital" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Herlev and Gentofte Hospital" with 2 trials sponsored, "Allarity Therapeutics" with 1 trials sponsored and "Apeiron Biologics" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herlev Gentofte Hospital" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Amager Hospital" with 1 trials as a collaborator, "Bispebjerg Hospital" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Herlev Gentofte Hospital" are "Myocardial Infarction" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Biliary Tract Cancer" (1 trials), "Breast Neoplasm" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "Herlev Gentofte Hospital" in a lesser frequency.

Most popular intervention types in "Herlev Gentofte Hospital" are "Drug" (8 trials), "Other" (5 trials), "Biological" (3 trials), "Diagnostic Test" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (1 trials), "Beta Blockers" (1 trials), "Cetuximab" (1 trials) and "Convalescent anti-SARS-CoV-2 plasma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herlev Gentofte Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Herlev Gentofte Hospital". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Herlev Gentofte Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Herlev Gentofte Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".